logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (v) New inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates4.939.129.814.36.43.41.11.022.43479389
Cocaine8.649.424.49.13.73.00.71.120.9569157
Stimulants15.661.314.74.32.50.60.90.218.8122770
Hypnotics and sedatives12.220.913.510.69.610.66.416.128.7311110
Hallucinogens0.047.423.710.57.95.35.30.023.33843
Volatile substances30.149.513.34.12.00.00.50.518.019610
Cannabis 38.847.39.22.71.10.60.30.117.11570282
Other substances 15.324.725.716.77.33.02.35.023.6300197
Total15.144.121.59.64.62.61.11.420.876901258
 

Notes:

Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012